Your browser doesn't support javascript.
loading
Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants.
Isokuortti, Harri; Iverson, Grant L; Posti, Jussi P; Berghem, Ksenia; Kotilainen, Anna-Kerttu; Luoto, Teemu M.
Afiliación
  • Isokuortti H; Department of Neurosurgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Iverson GL; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, United States.
  • Posti JP; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital and the Schoen Adams Research Institute at Spaulding Rehabilitation, Charlestown, MA, United States.
  • Berghem K; Neurocenter, Department of Neurosurgery, and Turku Brain Injury Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Kotilainen AK; Medical Imaging Centre, Department of Radiology, Tampere University Hospital, Tampere, Finland.
  • Luoto TM; Department of Surgery, Tampere University Hospital and Tampere University, Tampere, Finland.
Front Neurol ; 13: 952188, 2022.
Article en En | MEDLINE | ID: mdl-36570453
ABSTRACT

Background:

Serotonergic antidepressants may predispose to bleeding, but little is known of the risk for traumatic intracranial bleeding.

Methods:

This was a prospective case-control study of 218 patients with mild traumatic brain injuries (TBI) who were treated at a Finnish tertiary trauma hospital. Injury-related information and clinical findings were prospectively collected in the emergency department. Detailed pre-injury health history was collected from electronic medical records. Information on the use of serotonergic antidepressants was attained from the Finnish national prescription registry. All head CT scans were reviewed by a neuroradiologist based on the Common Data Elements. Cases were patients with traumatic intracranial hemorrhage on head CT. Controls were patients from the same cohort, but without traumatic intracranial lesions on CT. The proportion with traumatic intracranial bleeding for patients on serotonergic antidepressant medication was compared to the proportion for patients not on serotonergic medication.

Results:

The study cohort consisted of 24 cases with traumatic intracranial bleeding and 194 injured controls. The median age of the sample was 70 years (interquartile range = 50-83). One fifth (21.6%) of all the patients were taking a serotonergic antidepressant. Of the patients on an antidepressant, 10.6% (5/47) had an acute hemorrhagic lesion compared to 11.1% (19/171) of those who were not on an antidepressant (p = 0.927). In the regression analysis, traumatic intracranial hemorrhage was not associated with antidepressant use.

Conclusion:

Serotonergic antidepressant use was not associated with an increased risk of traumatic intracranial hemorrhage after a mild TBI. The patients in this relatively small cohort were mostly middle-aged and older adults. These factors limit the generalizability of the results in younger patients with mild TBI.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Finlandia